Want to see TLX full AI Analyst Report?

Telix Pharmaceuticals Limited Unsponsored ADR (TLX) Income Statement

6 Followers

Telix Pharmaceuticals Limited Unsponsored ADR Income Statement

Last quarter (Q2 2026), Telix Pharmaceuticals Limited Unsponsored ADR's total revenue was AU$691.36M, an increase of 265.87% from the same quarter last year. In Q2, Telix Pharmaceuticals Limited Unsponsored ADR's net income was AU$55.51M. See Telix Pharmaceuticals Limited Unsponsored ADR’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	AU$ 1.21B	AU$ 783.21M	AU$ 502.55M	AU$ 160.10M	AU$ 7.60M
Gross Profit	AU$ 640.23M	AU$ 509.68M	AU$ 314.39M	AU$ 94.93M	AU$ 5.05M
Operating Expenses	AU$ 613.59M	AU$ 427.55M	AU$ 263.27M	AU$ 186.86M	AU$ 53.30M
Depreciation and Amortization	AU$ 32.67M	AU$ 5.69M	AU$ 6.74M	AU$ 5.38M	AU$ 5.17M
EBITDA	AU$ 79.83M	AU$ 98.23M	AU$ 22.97M	AU$ -92.84M	AU$ -70.07M
Operating Income	AU$ 26.64M	AU$ 82.13M	AU$ 15.84M	AU$ -91.93M	AU$ -81.25M
Other Income/Expenses	AU$ -34.54M	AU$ -26.07M	AU$ -12.75M	AU$ -6.69M	AU$ -17.79M
Pretax Income	AU$ -7.90M	AU$ 56.06M	AU$ 3.09M	AU$ -98.62M	AU$ -99.04M
Net Income	AU$ -10.69M	AU$ 49.92M	AU$ 5.21M	AU$ -104.08M	AU$ -80.51M
Per Share Metrics
Basic EPS	AU$ -0.03	AU$ 0.15	AU$ 0.02	AU$ -0.34	AU$ -0.29
Diluted EPS	AU$ -0.03	AU$ 0.14	AU$ 0.02	AU$ -0.34	AU$ -0.29
Weighted Average Shares Outstanding	337.88M	331.23M	319.18M	310.64M	282.21M
Weighted Average Shares Outstanding (Diluted)	337.88M	345.19M	323.71M	310.64M	282.21M

Currency in AUD

Telix Pharmaceuticals Limited Unsponsored ADR (TLX) Income Statement

Telix Pharmaceuticals Limited Unsponsored ADR Income Statement

Telix Pharmaceuticals Limited Unsponsored ADR Earnings and Revenue History